首页> 美国卫生研究院文献>Nutrients >The Effect of the Yingyangbao Complementary Food Supplement on the Nutritional Status of Infants and Children: A Systematic Review and Meta-Analysis
【2h】

The Effect of the Yingyangbao Complementary Food Supplement on the Nutritional Status of Infants and Children: A Systematic Review and Meta-Analysis

机译:营养宝补充食品对婴儿和儿童营养状况的影响:系统评价和荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Yingyangbao (YYB) is a nutrient-dense complementary food supplement for infants and young children in China. There has been considerable interest and research on the potential effects of YYB on hematological and anthropometric outcomes in China, but limited effort has been made to consolidate and synthesize the evidence to inform the research and policy agendas. Eight English databases and three Chinese databases were searched from January 2001 to June 2019 to identify YYB intervention studies. A total of 32 quasi-experimental, post-only, concurrent-control studies or pre-post studies were identified, and 26 were included in the meta-analyses. A pooled analysis of post-only studies with concurrent-control determined that YYB was associated with an increase of 4.43 g/L (95% confidence interval (CI) 1.55, 7.30) hemoglobin concentration, 2.46 cm (CI 0.96, 3.97) in height, and 0.79 kg (CI 0.25, 1.32) weight in infants and young children. YYB was also associated with reductions in the prevalence of anemia (risk ratio (RR) = 0.55; 95% CI: 0.45, 0.67), stunting (RR = 0.60; 95% CI: 0.44, 0.81), and underweight (RR = 0.51; 95% CI: 0.39, 0.65). Overall, YYB was found to be associated with improved hematological and anthropometric indicators among infants and young children in China; however, randomized trials are needed to causally assess the efficacy of YYB due to the inherent risk of bias in existing quasi-experimental studies; rigorous implementation and cost-effectiveness evaluations are also needed.
机译:盈阳宝(YYB)是中国婴幼儿营养密集的补充食品补充剂。 YYB对中国血液学和人体测量学结果的潜在影响已经引起了广泛的兴趣和研究,但是在整合和综合证据以为研究和政策议程提供信息方面所做的努力有限。从2001年1月至2019年6月,检索了8个英文数据库和3个中文数据库,以识别YYB干预研究。总共鉴定了32项准实验研究,仅后期研究,并行对照研究或后期研究,其中26项纳入荟萃分析。一项仅进行后期研究且同时进行对照的汇总分析表明,YYB与血红蛋白浓度增加4.43 g / L(95%置信区间(CI)1.55,7.30),高度增加2.46 cm(CI 0.96,3.97)有关,婴儿和幼儿的体重为0.79千克(CI为0.25,1.32)。 YYB还与贫血患病率降低(风险比(RR)= 0.55; 95%CI:0.45,0.67),发育迟缓(RR = 0.60; 95%CI:0.44,0.81)和体重不足(RR = 0.51) ; 95%CI:0.39,0.65)。总体而言,在中国婴幼儿中,YYB与血液学和人体测量学指标的改善有关。然而,由于现有的准实验研究存在固有的偏倚风险,因此需要随机试验来评估YYB的疗效;还需要严格的实施和成本效益评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号